Mankind Pharma Limited (BOM:543904)
2,320.35
-57.40 (-2.41%)
At close: Jun 1, 2026
Mankind Pharma Revenue
In the fiscal year ending March 31, 2026, Mankind Pharma had annual revenue of 142.78B INR with 16.96% growth. Mankind Pharma had revenue of 34.43B in the quarter ending March 31, 2026, with 11.81% growth.
Revenue
142.78B
Revenue Growth
+16.96%
P/S Ratio
6.87
Revenue / Employee
7.28M
Employees
19,620
Market Cap
980.71B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 142.78B | 20.70B | 16.96% |
| Mar 31, 2025 | 122.07B | 19.47B | 18.98% |
| Mar 31, 2024 | 102.60B | 15.11B | 17.27% |
| Mar 31, 2023 | 87.49B | 9.68B | 12.44% |
| Mar 31, 2022 | 77.82B | 15.67B | 25.22% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Dr. Reddy's Laboratories | 335.93B |
| Lupin | 279.58B |
| Torrent Pharmaceuticals | 139.80B |
| Jubilant Pharmova | 82.80B |
| Abbott India | 69.29B |
| Granules India | 53.66B |
| J. B. Chemicals & Pharmaceuticals | 41.48B |
| GlaxoSmithKline Pharmaceuticals | 38.22B |
Mankind Pharma News
- 12 days ago - Mankind Pharma Transcript: Q4 25/26 - Transcripts
- 12 days ago - Mankind Pharma Quarterly report: Q4 2026 - Filings
- 12 days ago - Mankind Pharma Slides: Q4 2026 - Filings
- 4 months ago - Mankind Pharma Transcript: Q3 25/26 - Transcripts
- 4 months ago - Mankind Pharma Quarterly report: Q3 2026 - Filings
- 4 months ago - Mankind Pharma Slides: Q3 2026 - Filings
- 7 months ago - Mankind Pharma Transcript: Q2 25/26 - Transcripts
- 7 months ago - Mankind Pharma Quarterly report: Q2 2026 - Filings